Home » Topics » Regulatory

Regulatory
RSS

Lamictal approved for adjunctive use in pediatric partial seizures

Jan. 23, 2003

Asmanex Twisthaler launched in U.K.

Jan. 23, 2003

E.U. approves Taxotere in combination with cisplatin for first-line NSCLC treatment

Jan. 22, 2003

Chiesi's budesonide Modulite pMDI approved in Germany

Jan. 21, 2003

Novartis seeks approval for lower dose of Estalis in Sweden

Jan. 21, 2003

Caelyx approved in E.U. for metastatic breast cancer

Jan. 16, 2003

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

Approval of Coreg recommended for heart attack patients with impaired cardiac function

Jan. 15, 2003

Infliximab granted priority review by the FDA for fistulizing CD

Jan. 13, 2003

Type 2 diabetic patients complete first six-month treatment course with Metformin GR

Jan. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...